Dr Alan Landay

Alan Landay PhD is Professor in the Departments of Internal Medicine and Microbial Pathogens and Immunity  and is Assistant Provost for Team Science at Rush University Medical Center in Chicago.  He has been involved in HIV research for over 35 years having performed some of the first immune evaluations of HIV infected haemophiliacs in 1982 while completing a postdoctoral fellowship at the University of Alabama, Birmingham. His laboratory has made important original contributions in understanding the role of immune activation and inflammation in outcomes of non-communicable disease related to aging in the HIV population. This work has been translationally focused with my participation in the AIDS Clinical Trials Group and leading clinical trials on interventional strategies to reduce systemic inflammation and activation in the HIV population. He has extensive experience in aging related studies and has been PD/PI of an R24 grant that integrated efforts of the Center for AIDS Research and Older American Independence Centers. He has participated on the Office of AIDS Research HIV and Aging Committee and has been an advisor to UN AIDS on HIV and Aging. Over the past 10 years, his research focus has been on studies of the human microbiome and metabolome and better understanding its role both in health and disease, resulting in over 30 peer reviewed publications. He has been the Chair of the HIV and Microbiome working group for the Womens Interagency HIV Study and Co-Chair of the Microbiome Working Group for the AIDS Clinical Trial Group. He has chaired the International HIV and Microbiome meeting sponsored by the NIH for the last four years .  Dr. Landay has published over 450 peer reviewed papers focused on basic and clinical studies of HIV with an emphasis on the role of immune activation  inflammation and microbiome in HIV pathogenesis and therapy.